# Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)

> **NCT05798546** · PHASE1 · UNKNOWN · sponsor: **BGI, China** · enrollment: 21 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **BIOLOGICAL:** Neo-T
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine
- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT05798546
- **Lead sponsor:** BGI, China
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-28
- **Primary completion:** 2023-09
- **Final completion:** 2024-09
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2023-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05798546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05798546, "Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05798546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*